CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 370 enrolled
Drug / intervention
gentamicin sulfate +1 moredrug
Likely dose
gentamicin sulfate 80mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04246996
NCT04246996Phase 2Completed

Gentamicin Intravesical Efficacy for Infection of Urinary Tract

Kaiser Permanente·interventional·Posted Jan 29, 2020·Updated Nov 8, 2022

In Brief

A Phase 2 clinical trial evaluating gentamicin sulfate and Catheter clamping only for Postoperative Urinary Tract Infection and 2 related conditions. Completed, enrolled 370 participants across 2 sites.

Detailed Summary

Urinary tract infection (UTI) is a common problem after surgery for pelvic organ prolapse and stress urinary incontinence. This prospective, randomized, single-masked (subject), two-parallel armed study aims to determine the effect of a single postoperative intravesical instillation of 80 mg of gentamicin sulfate in 50 mL of saline versus usual care on the proportion of women treated for UTI within 6 weeks following surgery for pelvic organ prolapse (POP) or stress urinary incontinence (SUI).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 2CompletedFinished
2020202120222023202420252026
First PostedJan 29, 2020
Enrollment StartJan 29, 2020
Primary CompletionDec 5, 2021
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 6.4 years ago

Interventions

gentamicin sulfatedrug

Subjects in the gentamicin arm will receive an bladder instillation of 80mg of gentamicin sulfate in 50 mL of normal saline through a standard-of-care Foley catheter.

Catheter clamping onlyother

Subjects in the control arm will have their standard-of-care transurethral catheter clamped for 1 hour post-placement to maintain subject masking to study arm.